Serveur d'exploration SRAS - Checkpoint (Istex)

Index « Teeft.i » - entrée « Immunol »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Immunohistochemistry < Immunol < Immunol january  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]
Ident.Authors (with country if any)Title
000406 (2013) Vineet D. Menachery [États-Unis] ; Ralph S. Baric [États-Unis]Bugs in the system
000552 (2012) Federica Laudisi [Italie] ; Manolo Sambucci [Italie] ; Francesca Nasta [Italie] ; Rosanna Pinto [Italie] ; Rossella Lodato [Italie] ; Pierluigi Altavista [Italie] ; Giorgio Alfonso Lovisolo [Italie] ; Carmela Marino [Italie] ; Claudio Pioli [Italie]Prenatal exposure to radiofrequencies: Effects of WiFi signals on thymocyte development and peripheral T cell compartment in an animal model
000557 (2012) A. H. Werners ; C. E. Bryant [Royaume-Uni]Pattern recognition receptors in equine endotoxaemia and sepsis
000687 (2011) Emily M. Plummer [États-Unis] ; Marianne Manchester [États-Unis]Viral nanoparticles and virus‐like particles: platforms for contemporary vaccine design
000693 (2011) Che-Hsiung Hsu [Taïwan] ; Shang-Cheng Hung [Taïwan] ; Chung-Yi Wu [Taïwan] ; Chi-Huey Wong [Taïwan, États-Unis]Toward Automated Oligosaccharide Synthesis
000720 (2011) Monica L. Gavala [États-Unis] ; Paul J. Bertics [États-Unis] ; James E. Gern [États-Unis]Rhinoviruses, allergic inflammation, and asthma
000749 (2011) John Goulding [États-Unis] ; Vikas Tahiliani [États-Unis] ; Shahram Salek-Ardakani [États-Unis]OX40:OX40L axis: emerging targets for improving poxvirus‐based CD8+ T‐cell vaccines against respiratory viruses
000997 (2010) Edward P. Rybicki [Afrique du Sud]Plant‐made vaccines for humans and animals
000F49 (2008) Judith D. Easterbrook [États-Unis] ; Sabra L. Klein [États-Unis]Seoul virus enhances regulatory and reduces proinflammatory responses in male Norway rats
001091 (2008) Ivo M. B. Francischetti [États-Unis] ; Karl B. Seydel [États-Unis] ; Robson Q. Monteiro [Brésil]Blood Coagulation, Inflammation, and Malaria
001624 (2006) Takeshi Ichinohe [Japon] ; Izumi Watanabe [Japon] ; Eriko Tao [Japon] ; Satoshi Ito [Japon] ; Akira Kawaguchi [Japon] ; Shin-Ichi Tamura [Japon] ; Hidehiro Takahashi [Japon] ; Hirofumi Sawa [Japon] ; Masami Moriyama [Japon] ; Joe Chiba [Japon] ; Katsuhiro Komase [Japon] ; Yujiro Suzuki [Japon] ; Takeshi Kurata [Japon] ; Tetsutaro Sata [Japon] ; Hideki Hasegawa [Japon]Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant
001658 (2006) R. M. Dommett [Royaume-Uni] ; N. Klein [Royaume-Uni] ; M. W. Turner [Royaume-Uni]Mannose‐binding lectin in innate immunity: past, present and future
001884 (2005) ‘Genetics and The Immune Response’Abstracts of the 35th Annual Scientific Meeting of the Australasian Society for Immunology and 14th International HLA & Immunogenetics Workshop
001A52 (2005) J Rgen SlotsHerpesviruses in periodontal diseases
001D63 (2004) C M Roberts [Royaume-Uni]Short burst oxygen therapy for relief of breathlessness in COPD
001E04 (2004) D S Robinson [Royaume-Uni]Regulation: the art of control? Regulatory T cells and asthma and allergy
001E85 (2004) Ernesto Bonilla [Venezuela] ; Nereida Valero ; Leonor Chacín-Bonilla ; Shirley Medina-Leendertz [Venezuela]Melatonin and viral infections
002052 (2004) S K Weiland [Allemagne] ; N. Pearce [Nouvelle-Zélande]Asthma prevalence in adults: good news?
002056 (2004) W C Yu [République populaire de Chine] ; D S C. Hui [République populaire de Chine] ; M. Chan-Yeung [République populaire de Chine]Antiviral agents and corticosteroids in the treatment of severe acute respiratory syndrome (SARS)
002228 (2003) P. Bastone ; U. Truyen [Allemagne] ; M. Löchelt [Allemagne]Potential of Zoonotic Transmission of Non‐Primate Foamy Viruses to Humans
002328 (2003) K. Thestrup-Pedersen [Danemark, Arabie saoudite]Atopic eczema. What has caused the epidemic in industrialised countries and can early intervention modify the natural history of atopic eczema?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i -k "Immunol" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i  \
                -Sk "Immunol" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Immunol
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021